MARKET

RLFTF

RLFTF

Relief Therapeutics Hldg Ag
OTCMQB
3.250
NaN%
Closed 09:30 12/04 EST
OPEN
--
PREV CLOSE
3.250
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
18.88
52 WEEK LOW
2.340
MARKET CAP
40.87M
P/E (TTM)
-1.8990
1D
5D
1M
3M
1Y
5Y
1D
These Healthcare Stocks Just Exploded In Momentum — Investors Are Taking Notice
Benzinga · 1d ago
Weekly Report: what happened at RLFTF last week (1124-1128)?
Weekly Report · 4d ago
Relief Therapeutics and NeuroX Announce Strategic Business Combination
TipRanks · 11/25 06:33
Relief Therapeutics and NeuroX Reveal Joint Presentation and Financial Outlook Ahead of Anticipated Merger
Reuters · 11/25 06:02
Weekly Report: what happened at RLFTF last week (1117-1121)?
Weekly Report · 11/24 10:09
Weekly Report: what happened at RLFTF last week (1110-1114)?
Weekly Report · 11/17 10:08
Relief Therapeutics to Merge with NeuroX, Forming MindMaze Therapeutics
TipRanks · 11/14 17:31
Relief Therapeutics Shareholders Approve Merger with NeuroX
Reuters · 11/14 17:22
More
About RLFTF
RELIEF THERAPEUTICS Holding SA is a Switzerland-based biopharmaceutical company. The Company’s objective is to provide patients with therapeutic relief in serious diseases with high unmet medical need, as well as to focus on developing treatments for respiratory diseases. It specializes in clinical-stage projects based on molecules of natural origin (peptides and proteins with a history of clinical use and either initial human activity with efficacy data or a strong scientific rationale. Its lead compound is RLF-100 (aviptadil), a synthetic human vasoactive intestinal peptide (VIP) with a multifaceted mode of action in respiratory indications. RLF-100 is being investigated in two placebo-controlled U.S. phase 2b/3 clinical trials in respiratory deficiency due to COVID-19. Its RLF-100 is also used for pulmonary sarcoidosis. The Company is also involved in the clinical development of RLF-100 that is in planning stage for other indications in acute and chronic lung diseases.

Webull offers RELIEF THERAPEUTICS Holding SA stock information, including OTCMQB: RLFTF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RLFTF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RLFTF stock methods without spending real money on the virtual paper trading platform.